热门资讯> 正文
SHL远程医疗报告财年业绩
2024-04-17 17:18
- SHL Telemedicine press release (NASDAQ:SHLT): FY Net loss was $6.9m, compared to a net loss of $0.4M in FY2022.
- Revenue of $57.1M (+3.1% Y/Y).
- Adjusted EBITDA for the company was $2.1M, compared to $3.5M in 2022.
- Cash on hand and short-term cash investments as of December 31, 2023, remain robust at $26M
More on SHL Telemedicine
- Seeking Alpha’s Quant Rating on SHL Telemedicine
- Historical earnings data for SHL Telemedicine
- Financial information for SHL Telemedicine
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
